| scholarly article | Q13442814 |
| P50 | author | Qing-Zhu Kong | Q96066000 |
| Li-Tao Guo | Q96066001 | ||
| Jia-Ning Yang | Q96066003 | ||
| Yan-Fei Wang | Q96066004 | ||
| Jing-Xin Zhao | Q96066005 | ||
| Su-Hong Kong | Q96066006 | ||
| Meng Zhang | Q96066007 | ||
| Yu Jin | Q96066008 | ||
| P2093 | author name string | Shi Yan | |
| P2860 | cites work | The synovial proteome: analysis of fibroblast-like synoviocytes | Q21195678 |
| The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation | Q24296068 | ||
| The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner | Q24308947 | ||
| TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation | Q24313308 | ||
| The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells | Q24317705 | ||
| Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis | Q24598633 | ||
| The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor | Q24672820 | ||
| Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis | Q28239856 | ||
| TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1 | Q28513125 | ||
| TRAF-interacting protein (TRIP) is a RING-dependent ubiquitin ligase | Q28586346 | ||
| The pathogenesis of rheumatoid arthritis | Q29614957 | ||
| NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| Regulation of synovial cell apoptosis by proteasome inhibitor | Q33179130 | ||
| Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction | Q33245842 | ||
| Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression | Q33267068 | ||
| Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation | Q33648347 | ||
| Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. | Q34101406 | ||
| Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model | Q34168209 | ||
| TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation | Q34442208 | ||
| MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB. | Q53248446 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear f | Q59320253 | ||
| WIN-34B, a new herbal medicine, inhibits the inflammatory response by inactivating IκB-α phosphorylation and mitogen activated protein kinase pathways in fibroblast-like synoviocytes | Q84776911 | ||
| Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts | Q85927359 | ||
| Lipid peroxidation-mediated inflammation promotes cell apoptosis through activation of NF-κB pathway in rheumatoid arthritis synovial cells | Q35110153 | ||
| Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy | Q36151574 | ||
| The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis | Q36356204 | ||
| NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis | Q36490904 | ||
| Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation | Q36632268 | ||
| Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes | Q36637550 | ||
| NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint | Q36803920 | ||
| Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice | Q36813399 | ||
| IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients | Q37690200 | ||
| Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer | Q37988449 | ||
| Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors | Q38059458 | ||
| Expression of TNF-alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients. | Q38402453 | ||
| A Truncated Variant of ASCC1, a Novel Inhibitor of NF-κB, Is Associated with Disease Severity in Patients with Rheumatoid Arthritis | Q38824674 | ||
| TAK1 Lys-158 but not Lys-209 is required for IL-1β-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation | Q39623948 | ||
| The TRAF-Interacting Protein (TRIP) Is a Regulator of Keratinocyte Proliferation | Q39633328 | ||
| Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling | Q39785295 | ||
| TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation | Q41876154 | ||
| Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway | Q42713356 | ||
| USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation | Q42809464 | ||
| Cyclic GMP-AMP Synthase Is Required for Cell Proliferation and Inflammatory Responses in Rheumatoid Arthritis Synoviocytes | Q43097764 | ||
| Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy | Q45864343 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 3906108 | |
| P577 | publication date | 2016-10-26 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Anti-Inflammatory Effects of TRAF-Interacting Protein in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. | |
| P478 | volume | 2016 |
| Q55496778 | A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis. |
| Q50333623 | Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway |
| Q90669817 | Proinflammatory Effects of Ubiquitin-Specific Protease 5 (USP5) in Rheumatoid Arthritis Fibroblast-Like Synoviocytes |
Search more.